Lazolvan for inhalation has a secretolytic, secretomotor, expectorant properties. The drug has a stimulating effect against glandular serous cells in the bronchial mucosa. In addition, Lazolvan for inhalation increases the secretion of mucus and the release of surfactants in the bronchi and alveoli, normalizes the ratio of mucous and serous components of sputum. The medication helps to activate hydrolytic enzymes and enhance the release of lysosomes from Clara cells. Thus, Mucosolvan for inhalation reduces the viscosity of sputum, increasing its mucociliary transport, while increasing the motor activity of the cilia in the ciliated epithelium.
The drug is indicated for chronic and acute pathologies of the respiratory tract, accompanied by the formation of a viscous secretion. These diseases include:
- bronchitis;
- rhinitis, sinusitis;
- bronchiolitis;
- bronchial asthma;
- cystic fibrosis;
- bronchiectasis.
Lazolvan for inhalation is not used for hypersensitivity, as well as during the first trimester of pregnancy, in the second and third - the drug is used with extreme caution and under the constant supervision of a doctor. In addition, the appropriateness of the appointment is determined by the doctor during lactation, as well as in case of liver or kidney failure.
Lazolvan. Mode of application
In the inhaler, the drug is mixed with saline. The ratio is one to one.
Children under six years of age are given one or two inhalations of 2 ml daily, from seven years of age and adults - from 2 to 3 ml can be used.
The use of a medicinal solution can provoke side effects in some cases. In practice, allergic reactions were noted in the form of angioedema, rash, urticaria, allergic contact dermatitis (extremely rare).
Long-term use of high doses of the drug can provoke vomiting, gastralgia, heartburn, nausea.
Extremely rare were cases of acute severe anaphylactic reactions.
The medication is compatible with drugs that inhibit labor activity. The use of Lazolvan in combination with antitussive drugs causes difficulties in sputum discharge against the background of a decreasing cough. The drug is able to increase the penetration of cefuroxime, amoxicillin, doxycycline and erythromycin into the bronchial secretion.
As observations show, today inhalers are quite firmly embedded in human life. In this regard, medicine is trying to adapt to them. That is why new dosage forms appear in pharmacies. One of these forms is Lasolvan for inhalation. Reviews in most cases after using the drug are positive. Many note its effectiveness. According to a large number of patients, such a dosage form does not negatively affect the stomach. Lazolvan acts after some time. Noticeable relief is noted on the second day.
The solution can also be used orally. But, due to its bitter taste, it is used mainly in an inhaler.
Despite the relatively high cost, according to many patients, Lazolvan justifies the cost.
It should be noted that there are cases when patients did not feel the effect. Such phenomena arise due to various factors, including the individual characteristics of the body, as well as the course and nature of the disease that they are trying to fight.
That is why a specialist consultation is recommended before using medicines. Self-medication should not be practiced, especially children should not be independently selected for therapy.